Prophylaxis against recurrence of HBV hepatitis after living-donor liver transplantation

Hepato-Gastroenterology

Volumn 55, Issue 86-87, 2008, Pages 1746-1749

  Tashiro, Hirotaka ^a   Itamoto, Toshiyuki ^a   Fudaba, Yasuhiro ^a   Ohdan, Hideki ^a   Fukuda, Saburo ^a   Kohashi, Toshihiko ^a   Amano, Hironobu ^a   Ishiyama, Kohei ^a   Ide, Kenntaro ^a   Ogawa, Takayuki ^a   Shishida, Masayuki ^a   Irei, Toshimitsu ^a   Ushitora, Yuichiro ^a   Ohira, Masahiro ^a   Takahashi, Shoichi ^a   Chayama, Kazuaki ^a   Asahara, Toshimasa ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis B; Hepatitis B immunoglobulin; Lamivudine; Living donor liver transplantation; Recurrence

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; DOSE RESPONSE; FEMALE; HEPATITIS B; HUMAN; INFECTION PREVENTION; INTERVENTION STUDY; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; AGED; DNA, VIRAL; FEMALE; HEPATITIS B; HUMANS; IMMUNOGLOBULINS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RECURRENCE;

EID: 57049139385     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H, and the investigators of the European concerted on viral hepatitis study: Liver transplantation in European patients with the hepatitis B surface antigen. New Engl Med 1993; 329:1842-1847.
2. Davies SE, Portman BC, O'Grady IG: Hepatic histologic findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13:150.
3. Shouval D, Samuel D: Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review. Hepatology 2000; 32:1189-1195.
4. Han SH, Ofman J, Holt C, et al: An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transplant 2000; 6:741-748.
5. Yao FY, Osoric, RW, Roberts JP, Poordad FF, Briceno MN, Kennedy RG, Gish RR: Intramuscular hepatitis B immune globulin comgined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation. Liver transplantation 1999; 5:491-496.
6. Dumottier J, Chevallier P, Scoazee JY, Berger and Boillot O: Combination lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results. Am J Transplant 2003; 3:999-1002.
7. Allen MI, Deslauriers M, Andrews CW, et al: Identification and characterization of mutants in hepatitis B virus resistant to lamivudine. Lamivudine clinical investigation group. Hepatology 1998; 27:1670-1677.
8. Tripples GA, Ma MM, Fischer KP, Bain VG, Knetemann NM, Tynell DL: Mutation in HBV RNA-dependent DNA polyroerase confers resistance to lamivudine in vivo. Hepatology 1996; 24:714-717.
9. Markowitz JS, Martin P, Conard AL, Markmarm JF, Seu P, Yersiz H, Goss JA, Schmidt P, Pakrasi A, Artinian L, Murray NGB, Imagawa DK, Holt C, Goldstein LI, Stribling R, Busuttil RW: Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudme and hepatitis B immune globulin. Hepatology 1998; 28:585-589.
10. Faust D, Rabenau HF, Allewinn R, Caspary WF, Zeuem S: Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation. Clinical Transplantation 2003; 17:254-258.
11. Lo CM, Fan ST, Liu CL, Lai CL, Wong J: Prophylaxis and treatment of recurrent hepatitis B after liver transplantation. Transplantation 2003; 75:S41-S44.
12. A Marzano, S Gaia, V Ghisetti, S Carenzi, A Premoli, WD Venon, C Alessandria, A Franchello, M Salizzoni and M Rizzetto: Viral load at the time liver transplantation and risk of hepatitis B virus recurrence. Liver Transplant 2005; 11:402-409.
13. DiPaolo D, Tisone G, Piccolo P, Lenci I, Zazza S, Angelico M: Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis b virus infection in the long-term follow-up after liver transplantation. Transplantation 2004; 77:1203-1208.
14. Angus PW, McCaughan GW, Gane EJ, Crawford DHG, Harley H, and the Australasian liver transplant study group: Combination low-dose-hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver Transplant 2000; 6:429-433.
15. Sugawara Y, Makuuchi M, Kaneko J, Akamatsu N, Imamura H and Kokudo, N. Living donor liver transplantation for hepatitis B cirrhosis. Liver Transplant 2003; 9:1181-1184.
16. Mutimer D, Feraz-Neto BH, Harriosn R, et al: Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir. Gut 2001; 49:860-863.
17. Walsh KM, Woodall T, Lamy P, Wight DG, Bloor S, Alexznder GJ: Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus. Gut 2001; 49:436-440.
18. Seehofer D, Rayes N, Naumann U, et al: Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation. Transplantation 2001; 72:1381-1385.
19. Neff GW, O'Brien CB, Nery J, Shire N, Montalbano M, Ruiz P, Nery C, Safdar K, Medina MD, Tzakis AG, Schiff ER, Madariaga J: Outcome in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade. Liver Transplant 2004; 10:1372-1378.
20. Schiff ER, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, Tillmann HL, et al: Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre-and post-liver transplantation patients. Hepatology 2003; 38:1419-1427.